PENFLURIDOL (R 16 341) AS A MAINTENANCE THERAPY IN CHRONIC PSYCHOTIC PATIENTS: A DOUBLE‐BLIND CLINICAL EVALUATION

@article{Roelofs1974PENFLURIDOL1,
  title={PENFLURIDOL (R 16 341) AS A MAINTENANCE THERAPY IN CHRONIC PSYCHOTIC PATIENTS: A DOUBLE‐BLIND CLINICAL EVALUATION},
  author={G. Roelofs},
  journal={Acta Psychiatrica Scandinavica},
  year={1974},
  volume={50}
}
  • G. Roelofs
  • Published 1974
  • Medicine
  • Acta Psychiatrica Scandinavica
    • A double‐blind, 6‐month trial of penfluridol and placebo was conducted in 15 chronic psychotic patients in the age range of 25–64 years. The patients, who had been well controlled with penfluridol for several months, were divided into two comparable groups with seven patients receiving penfluridol and eight receiving placebo. Dexetimide and other non‐psychotropic drugs already taken before the trial were continued. Each patient was assessed before and after 1, 2, 4 and 6 months of treatment… CONTINUE READING
    View on Wiley
    ncbi.nlm.nih.gov
    9 Citations

    Topics from this paper

    Explore Further: Topics Discussed in This Paper

    9 Citations
    Citation Type

    Citation Type

    A DOUBLE‐BLIND CLINICAL EVALUATION OF PENFLURIDOL (R 16 341) AS A MAINTENANCE THERAPY IN SCHIZOPHRENIA
    • 7
    PERORAL AND PARENTERAL ADMINISTRATION OF LONG‐ACTING NEUROLEPTICS: A DOUBLE‐BLIND STUDY OF PENFLURIDOL COMPARED TO FLUPENTHIXOL DECANOATE IN THE TREATMENT OF SCHIZOPHRENIA
    • 14
    Penfluridol steady‐state kinetics in psychiatric patients
    • 6
    Controlled trial of penfluridol and thiothixene in the maintenance treatment of chronic schizophrenic syndromes
    • 12
    Penfluridol for schizophrenia.
    • 22
    The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics
    • 44
    Depot Antipsychotic Drugs
    • 106
    Maintenance treatment with antipsychotic drugs for schizophrenia.
    • 168
    A historical review of placebo-controlled, relapse prevention trials in schizophrenia: The loss of clinical equipoise

    References

    SHOWING 1-10 OF 14 REFERENCES
    Penfluridol: A Long‐Acting Oral Neuroleptic.
    • 14
    • Highly Influential
    Controlled trial of penfluridol in acute psychosis.
    • 30
    Blood and neoplastic diseases. Solid tumours in children.
    • 17
    • PDF
    Interaction between neuroleptic therapy and sociotherapeutic approach an investigation with penfluorid and haloperidol.
    • 3
    Penfluridol (R 16 341), a long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients
    • Psychiat. Neurol. Neurochir
    • 1973
    FLUSPIRILENE, AN INJECTABLE, AND PENFLURIDOL, AN ORAL LONG‐ACTING, NEUROLEPTIG
    • 15
    Fluspirilene, an injectable, and penfluridol, an oral long-acting, neuroleptic. A comparative double-blind trial in residual schizophrenia.
    • 8
    Pimozide treatment of chronic schizophrenics as compared with jialoperidol and penfluridol maintenance treatment
    • Acta Psychiat . ( Belg . )
    • 1972
    Clinical evaluation of the weekly oral administration of penfluridol (R 16 341) in chronic psychotic patients
    • Seventh Congress of the Collegium International Neuro-Psychopharmacologicum, Prague, Czechoslovakia. (Available on request to the Janssen Research Products Information Service)
    • 1970
    Clinical evaluation of the weekly oral administration of penfluridol (R 16 341) in chronic psychotic patients. Seventh Congress of the Collegium International Neuro-Psychopharmacologicum
    • 1970